Funding · Healthcare & Life Sciences

Bioscan Research raises $1M seed funding

By Startup Enthusiast · 22 July 2026

What they do

Bioscan Research makes non-invasive devices to detect brain injuries using optics and machine learning

It raised a $1M seed round led by Unicorn India Ventures, a deeptech-focused VC

The company has grown 5X in the past year and plans to expand in India and international markets

Bioscan Research raised $1M in seed funding.
The round was led by Unicorn India Ventures, an early-stage VC with a deeptech focus.
The company makes non-invasive devices to detect traumatic brain injuries using optics and machine learning.
Its flagship product is CEREBO, a machine learning-powered NIRS (near-infrared spectroscopy) device.
The funds will be used for market expansion, regulatory approvals, product upgrades, and new IP creation.
The company plans to expand in India and international markets.
Bioscan Research has grown 5X over the past 12 months and targets 3X growth in the next year.

Over 50 million people suffer traumatic brain injuries annually worldwide.
Between 50% and 90% of mild TBIs go unidentified.
Traditional imaging is not always accessible, especially in emergencies or resource-constrained settings.
Bioscan's device aims to fill this gap with a portable, non-invasive solution.

Bioscan Research is a medtech startup founded in 2017.
It develops non-invasive brain injury detection devices using optics, electronics, mechanics, and software.
Its flagship product CEREBO uses machine learning and NIRS (near-infrared spectroscopy) to detect intracranial injuries.
The company is headquartered in Mumbai.
It has achieved 5X growth in the past 12 months.

Unicorn India Ventures (lead) — Early-stage VC founded in 2016, focused on deeptech including semiconductors, spacetech, AI infrastructure, and medical diagnostics.

Product: CEREBO: non-invasive medical device using near-infrared spectroscopy (NIRS) and machine learning for early brain injury detection
Customers: Healthcare providers, hospitals and trauma centers for diagnostic and patient management
How it makes money: B2B medical device sales with technology licensing and service operations
What sets it apart: Non-invasive detection of intracranial injuries at pre-symptomatic phase with machine learning powered analysis
Operations: Combines optics, electronics, mechanics and software for deeptech medical applications